Mary Ann Liebert, Inc., publishers

Mary Ann Liebert, Inc., publishers Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from Mary Ann Liebert, Inc., publishers, Publisher, 140 Huguenot Street, New Rochelle, NY.

Global media company dedicated to creating, curating, and delivering impactful peer-reviewed research and authoritative content to advance biotechnology, life sciences, specialized clinical medicine, and public health policy.

02/06/2025

🔬 Call for Papers: Special Issue on Toxicity and Safety in Clinical AAV Gene Therapy 🧬

The field of AAV gene therapy is advancing rapidly, but emerging challenges around toxicity and safety remain critical. Human Gene Therapy invites original research, reviews, and mini-reviews for a 2025 Special Issue focused on:

✅ AAV-related toxicities, including liver toxicity, cardiotoxicity, immune myositis, and thrombocytopenia
✅ Mechanisms of toxicity in AAV delivery
✅ Innovations in vector design and recipient therapies to enhance safety
✅ Standardized protocols for immunologic assays

📅 Submission Deadline: April 2025
📝 Impact Factor: 4.1 | Avg. Time to Decision: 21 days

Expand the global conversation on AAV safety! Submit your research today:
🔗 https://hubs.li/Q035t9ml0

🚀 New Supplement Alert! Explore the latest Diabetes Technology & Therapeutics supplement, supported by Medtronic, featur...
02/05/2025

🚀 New Supplement Alert!

Explore the latest Diabetes Technology & Therapeutics supplement, supported by Medtronic, featuring cutting-edge advancements in hybrid closed-loop systems, glucose monitoring, and the future of diabetes care. This must-read collection brings expert insights into the evolving landscape of AI-driven diabetes management.

🔗 Read the full supplement: https://hubs.li/Q035glNt0

02/04/2025

📢 AI in Neuroscience (AINS) is now accepting submissions! Are you researching AI applications in neuroscience? This is your opportunity to contribute to an exciting new journal dedicated to groundbreaking discoveries.

✅ Share your work with a global audience
✅ Explore the latest advancements in AI-driven neuroscience
✅ Be part of a growing community at the forefront of innovation

Whether you're a PhD student, postdoc, or experienced researcher, we invite you to submit your latest findings and help shape the future of neuroscience.

🔗 Learn more: https://hubs.ly/Q035cdty0

🧠 Enhancing Post-Acute Care for Traumatic Brain Injury (TBI) 🏥A new study in Journal of Neurotrauma outlines key clinica...
01/31/2025

🧠 Enhancing Post-Acute Care for Traumatic Brain Injury (TBI) 🏥

A new study in Journal of Neurotrauma outlines key clinical actions to improve care for non-hospitalized TBI patients, including early education, return-to-activity guidance, mental health screening, and specialist referrals.

Standardizing these steps in primary care can support recovery and prevent long-term complications.

🔗 Read the full article: https://hubs.li/Q034YfjD0

01/30/2025

Special Issue Alert: AI in Tissue Engineering

Explore groundbreaking research at the intersection of AI and tissue engineering in this special issue of Tissue Engineering. Guest-edited by experts from Stanford University School of Medicine, this collection highlights cutting-edge advancements, including:

🧠 Deep Learning Augmented Osteoarthritis Grading Standardization
🩺 Hematoxylin and Eosin Architecture Uncovers Clinically Divergent Niches in Pancreatic Cancer

Enjoy free access through February 12, 2025! Don’t miss this opportunity to stay ahead in AI-driven biomedical innovation.

📖 Read & Share Now: 🔗 Access the issue
https://hubs.li/Q034Mkqr0

🔬 Guest Editors:
🔹 Jason L. Guo, PhD
🔹 Michael Januszyk, MD
🔹 Michael T. Longaker, MD
📍 Stanford University School of Medicine

🛑 Announcing the 2025 Allergen of the Year! 🛑The The American Contact Dermatitis Society has named Toluene-2,5-Diamine S...
01/30/2025

🛑 Announcing the 2025 Allergen of the Year! 🛑

The The American Contact Dermatitis Society has named Toluene-2,5-Diamine Sulfate (PTDS) as the Allergen of the Year 2025 to raise awareness of its dual role—both as an allergen and as an alternative for some individuals allergic to para-phenylenediamine (PPD).

PTDS is commonly found in hair dyes and has been linked to allergic contact dermatitis, making it a significant concern for consumers and professionals alike.

🔬 Learn more about the science behind this designation: https://hubs.ly/Q034LnrD0

📢 Top-Rated on Altmetric! One of our most impactful articles this past week was featured by MedPage Today!🔬 "The Virtual...
01/29/2025

📢 Top-Rated on Altmetric! One of our most impactful articles this past week was featured by MedPage Today!

🔬 "The Virtual DCCT: Adding Continuous Glucose Monitoring to a Landmark Clinical Trial for Prediction of Microvascular Complications" (published 1/8/2025, in DIA) was cited in their piece: "High-Strength Wegovy; Aldosteronism Outcome Definitions; Insulin Unit Price Down 42%."

🔗 Read the full article: https://hubs.li/Q034x5Zl0

Tune in TOMORROW, January 29th, for the State of Cell and Gene Therapy virtual summit, hosted by GEN. This virtual event...
01/28/2025

Tune in TOMORROW, January 29th, for the State of Cell and Gene Therapy virtual summit, hosted by GEN. This virtual event features a fantastic group of presenters from academia and industry to discuss the latest clinical advances and trends. Through a series of keynote presentations, panel discussions and fireside chats, our speakers will discuss progress and challenges around new technologies, delivery vehicles, and clinical applications.

Highlights of the summit include:

☑️Opening keynote on the state of CAR-T therapy by 2024 Breakthrough Prize winner Michel Sadelain
☑️Progress and lessons 12 months after the historic approval of Casgevy, the first CRISPR-based medicine
☑️Gene therapy for rare and ultra-rare diseases: a fireside chat with Terence Flotte
☑️The viral vs non-viral delivery debate with Nicole Paulk and Ross Wilson
☑️Top 5 challenges facing cell and gene therapy with veteran executive Federico Mingozzi
☑️A roundtable on advances in gene therapy for hearing loss
☑️Technology breakout sessions hosted by all of the summit sponsors
And much more!

Thanks to our sponsors, registration is completely free! Sign up today and join us at 11:00am ET tomorrow.
https://hubs.li/Q034pz990

Final days to register for GEN's second annual State of Cell and Gene Therapy virtual summit. Tune in on January 29th fo...
01/27/2025

Final days to register for GEN's second annual State of Cell and Gene Therapy virtual summit. Tune in on January 29th for an exciting day of expert-led sessions discussing the latest advances and challenges in the world of cell and gene therapy. Hear from Nicole Paulk, PhD (Siren Biotechnology) in the session "Discussing Delivery: Advances in AAVs, LNPs and More"

To register for free, visit:
https://hubs.li/Q0347V8G0

Only one week left to register for the State of Cell and Gene Therapy virtual summit, hosted by GEN. You’ll hear from a ...
01/24/2025

Only one week left to register for the State of Cell and Gene Therapy virtual summit, hosted by GEN. You’ll hear from a superb line-up of experts and thought leaders from industry and academia discussing the latest advances and challenges in the world of cell and gene therapy. Tune in to see Federico Mingozzi, PhD in his session "Top 5 challenges facing cell and gene therapy".

To register for free, visit: https://hubs.li/Q033SPGY0

🌟 Explore Groundbreaking Open Access Research 🌟Open access research drives innovation and shapes the future of your fiel...
01/21/2025

🌟 Explore Groundbreaking Open Access Research 🌟

Open access research drives innovation and shapes the future of your field. That's why we've curated collections featuring some of the most impactful, widely-cited studies.

We're excited to share the tenth collection in our Open Impact Series, spotlighting thought-leading research in endocrinology. Dive into cutting-edge studies that your colleagues are already using to inform their work.

Read this collection today: https://hubs.li/Q033jqch0

Be sure to register for the upcoming State of Cell and Gene Therapy virtual summit happening January 29th! GEN has gathe...
01/21/2025

Be sure to register for the upcoming State of Cell and Gene Therapy virtual summit happening January 29th! GEN has gathered a fantastic group of presenters from academia and industry to discuss the latest clinical advances and trends across the field of cell and gene therapy. Among them, hear from Michel Sadelain (Inaugural Director of the Columbia Initiative in Cell Engineering and Therapy, Columbia University) in his "CARs in 2025: the Cambrian Explosion Continues" keynote.

To register for FREE, visit: https://hubs.li/Q033g2bP0

🌟 Exciting news! Mary Ann Liebert, Founder of Mary Ann Liebert, Inc., recently spoke to The Scholarly Kitchen, the offic...
01/16/2025

🌟 Exciting news! Mary Ann Liebert, Founder of Mary Ann Liebert, Inc., recently spoke to The Scholarly Kitchen, the official blog of the Society for Scholarly Publishing (SSP), for an in-depth Q&A about the transformative Sage Publications acquisition and its impact on the independent academic publishing landscape. 🧬📚

In this exclusive interview, Mary Ann shares how her early experiences shaped her remarkable career. While studying journalism in college, she was driven by a determination to find published research that could benefit her father, who had Parkinson’s disease. Though she didn’t find the breakthrough she hoped for, the search ignited her passion for scientific publishing and the vital role of peer-reviewed research in advancing medicine.

Over 40+ years, Mary Ann has built a legacy of innovation, launching pioneering journals that have defined emerging fields of research. The conversation also delves into her thoughts on independent publishing, the evolution of open access, and why partnering with Sage marks the next exciting chapter for Mary Ann Liebert, Inc.

📖 Read the full interview to discover how Mary Ann’s insatiable curiosity continues to inspire innovation and impact in the world of scholarly publishing: https://hubs.li/Q032QqBq0

🚀 The Preview Issue of AI in Neuroscience is here! 🌟Discover a groundbreaking multidisciplinary journal at the intersect...
01/16/2025

🚀 The Preview Issue of AI in Neuroscience is here! 🌟

Discover a groundbreaking multidisciplinary journal at the intersection of artificial intelligence and neuroscience. AI in Neuroscience explores how AI is revolutionizing neurological research, clinical practice, and medical technology—paving the way for significant advancements in patient care.

💡 Don’t miss the full Inaugural Issue, coming this March!
📚 Libraries and professionals: Contact us today to subscribe and take advantage of introductory incentives!

👉 Read the Preview Issue now: https://hubs.li/Q032JQXv0

01/16/2025

🚨 New Research Alert! 🚨
A groundbreaking study published in Thyroid®, the official journal of the American Thyroid Association®, finds no evidence linking GLP1 receptor agonists (GLP1-RAs)—widely used for treating type 2 diabetes and obesity—to an increased risk of thyroid cancer.

🔬 This large-scale study, led by Professor Anton Pottegård (Syddansk Universitet – University of Southern Denmark), analyzed data from over 92,000 GLP1-RA users across six countries, providing critical reassurance about the short-term safety of these medications.

📖 Read the full article here: https://hubs.li/Q032JSHD0

💡 Thyroid® is the leading, peer-reviewed resource for original articles, patient-focused reports, and translational research on thyroid cancer and all thyroid related diseases.. Dive into more cutting-edge findings today!

We are thrilled to welcome Respiratory Care, the official journal of the American Association for Respiratory Care - AAR...
01/15/2025

We are thrilled to welcome Respiratory Care, the official journal of the American Association for Respiratory Care - AARC , to the Mary Ann Liebert family! 🎉

📖 Explore the January 2025 issue here: https://hubs.li/Q032Fr-P0

Respiratory Care is the premier peer-reviewed journal on cardiorespiratory disorders, essential for respiratory therapists, pulmonologists, and healthcare professionals worldwide.

💼 Ensure seamless access to this critical resource for your library – contact us for subscriptions, archive access, or tailored packages!

🌟 Congratulations, Bill Nye! 🌟We are honored to celebrate New Space Editorial Board Member, William Sanford Nye, BS—know...
01/09/2025

🌟 Congratulations, Bill Nye! 🌟

We are honored to celebrate New Space Editorial Board Member, William Sanford Nye, BS—known to many as Bill Nye the Science Guy—on being awarded the Presidential Medal of Freedom by President Joe Biden.

This prestigious honor highlights his dedication to science education, his impactful leadership as CEO of the Planetary Society, and his tireless advocacy for space exploration and environmental stewardship.

As a proud member of the New Space team, William Nye continues to inspire innovation and a passion for the cosmos.

Learn more about New Space, the premier journal for space entrepreneurship and innovation: https://hubs.li/Q031TKsr0

📸: Bill Nye receiving the medal at the White House, January 4, 2025. (Photo by Tom Brenner/Getty Images)

Happy Holidays from Mary Ann Liebert, Inc. 🎉As this year comes to a close, we wish you and your loved ones a holiday sea...
12/20/2024

Happy Holidays from Mary Ann Liebert, Inc. 🎉

As this year comes to a close, we wish you and your loved ones a holiday season filled with joy, peace, and happiness. May the New Year bring new opportunities, continued success, and brighter days ahead.

Thank you for being part of our community and for your support throughout the year.

Address

140 Huguenot Street
New Rochelle, NY
10801

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Telephone

(914) 740-2100

Alerts

Be the first to know and let us send you an email when Mary Ann Liebert, Inc., publishers posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Mary Ann Liebert, Inc., publishers:

Videos

Share

Category

About Us

Founded by Mary Ann Liebert in 1980, Mary Ann Liebert, Inc. is a leading independent publisher with a portfolio of over 90 peer-reviewed journals, leading trade magazines, and newsletters, in addition to society membership management and conferences.

Our publications focus on cutting-edge fields such as biotechnology, biomedical research, medicine and surgery, public health research and policy, technology and engineering, law, environmental research and policy, and other specialized disciplines.

We are, however, more than just a publisher. Mary Ann Liebert, Inc. collaborates effectively with corporations, educational institutions, nonprofit foundations, and is committed to meeting the needs of the members of academia, government, and industry around the world.

Browse our publications, explore the content of our established journals, and learn more about our extensive capabilities here: https://www.liebertpub.com/